44	How much impact do masks have on preventing the spread of the COVID-19? masks, COVID-19, mask effectiveness, virus transmission, mask prevention, respiratory droplets, face coverings, public health, infection control, pandemic, mask impact, disease spread, protective measures, coronavirus prevention masks, COVID-19, prevention, impact, effectiveness, transmission, face coverings, virus spread, respiratory droplets, public health, infection control, mask efficacy masks, COVID-19, mask effectiveness, transmission prevention, coronavirus, face coverings, mask impact, infection control, airborne transmission, public health, disease spread, respiratory viruses, pandemic, mask mandate, safety measures masks, COVID-19, prevention, spread, effectiveness, impact, mask efficacy, viral transmission, face coverings, infectious disease, protective measures, public health, coronavirus, mask mandate, respiratory droplets masks, COVID-19, mask effectiveness, mask impact, disease transmission, virus prevention, COVID-19 spread, infection control, mask protection, public health, respiratory viruses, face coverings, mask studies, epidemiology, mask efficacy
45	How has the COVID-19 pandemic impacted mental health? COVID-19, pandemic, mental health, psychological impact, anxiety, depression, stress, emotional wellbeing, lockdown effects, social isolation, public health, mental health disorders, COVID-19 effects, psychological distress, quarantine, mental health consequences COVID-19, pandemic, mental health, psychological impact, emotional well-being, anxiety, depression, stress, lockdown effects, social isolation, public health, mental illness, pandemic effects, well-being, mental disorders COVID-19, pandemic, mental health, psychological impact, anxiety, depression, stress, lockdown, social isolation, emotional well-being, quarantine, public health, mental disorders, coping strategies COVID-19, pandemic, mental health, psychological impact, anxiety, depression, stress, social isolation, lockdown, quarantine, mental health services, emotional wellbeing, pandemic effects, mental health outcomes, public health, trauma, crisis intervention COVID-19, pandemic, mental health, psychological impact, coronavirus, stress, anxiety, depression, lockdown, quarantine, emotional wellbeing, public health, social isolation, behavioral health, mental disorders
46	what evidence is there for dexamethasone as a treatment for COVID-19? dexamethasone, COVID-19, treatment, evidence, clinical trials, research studies, efficacy, outcomes, corticosteroids, RECOVERY trial, mortality, severe COVID-19, randomized controlled trials, inflammation, respiratory failure dexamethasone, COVID-19, treatment, evidence, clinical trials, efficacy, corticosteroids, RECOVERY trial, outcomes, mortality, severe COVID-19, randomized controlled trial, anti-inflammatory, SARS-CoV-2, hospitalization dexamethasone, COVID-19, treatment, evidence, clinical trials, efficacy, studies, outcomes, mortality, recovery, respiratory failure, corticosteroids, randomized controlled trial, RECOVERY trial dexamethasone, COVID-19, treatment, evidence, clinical trials, efficacy, coronavirus, randomized controlled trials, RECOVERY trial, outcomes, mortality reduction, severe COVID-19, steroid therapy, hospital patients, published studies dexamethasone, COVID-19, treatment, evidence, clinical trials, efficacy, corticosteroids, RECOVERY trial, outcomes, mortality, severe COVID-19, randomized controlled trial, immune response, inflammation, therapeutic benefits
47	what are the health outcomes for children who contract COVID-19? children, COVID-19, pediatric, health outcomes, infection, effects, risks, complications, prognosis, symptoms, morbidity, mortality, long-term effects, disease severity children, COVID-19, health outcomes, pediatric, coronavirus, infection, effects, complications, symptoms, prognosis, disease severity, risk factors, long-term effects, recovery, transmission, morbidity, mortality children, COVID-19, health outcomes, pediatric, infection, coronavirus, disease severity, complications, symptoms, long-term effects, hospitalization, risk factors, recovery, mortality, comorbidities children, COVID-19, health outcomes, pediatric, coronavirus, infection, effects, risks, symptoms, complications, prognosis, hospitalization, long-term effects, severity, recovery, mortality, impact, clinical outcomes, disease progression, young patients children, COVID-19, health outcomes, pediatric, infection, symptoms, complications, recovery, long-term effects, morbidity, mortality, risk factors, severity, hospitalization, prognosis
48	what are the benefits and risks of re-opening schools in the midst of the COVID-19 pandemic? school reopening, COVID-19, benefits, risks, pandemic, education, public health, student safety, learning loss, infection rates, mental health, transmission, remote learning, social impact, policy, mitigation measures COVID-19, schools reopening, benefits, risks, pandemic, education, public health, students, safety measures, transmission, infection rates, mental health, learning loss, community spread, policy decisions, vaccine availability, mask mandates, remote learning, teacher safety, social distancing school reopening, COVID-19, pandemic, benefits, risks, education, health, safety, children, students, transmission, infection, public health, learning loss, mental health, teachers, social distancing, prevention measures, community spread re-opening schools, COVID-19, coronavirus, pandemic, benefits, risks, school safety, public health, student health, transmission, infection rates, education impact, remote learning, mental health, community spread, school policies, mitigation strategies, children, teachers, school staff, social distancing, masks, vaccination, government guidelines re-opening schools, COVID-19, pandemic, benefits, risks, education, health impact, student safety, public health, transmission, infection rates, mental health, learning loss, government guidelines, school policy, remote learning, in-person classes, teachers, parents, children
49	do individuals who recover from COVID-19 show sufficient immune response, including antibody levels and T-cell mediated immunity, to prevent re-infection? COVID-19, immune response, recovered individuals, antibody levels, T-cell mediated immunity, reinfection prevention, immunity duration, SARS-CoV-2, immune memory, protective immunity, humoral response, cellular immunity, neutralizing antibodies, long-term immunity, relapse risk COVID-19, recovered individuals, immune response, antibody levels, T-cell immunity, reinfection prevention, immunity duration, SARS-CoV-2, adaptive immunity, immune protection, humoral response, cellular immunity, reinfection risk, immune memory, neutralizing antibodies COVID-19, immune response, antibody levels, T-cell immunity, reinfection, immunity after recovery, SARS-CoV-2, immunological memory, protective immunity, convalescent patients, immune protection, neutralizing antibodies, T lymphocytes, secondary infection, immunological response COVID-19, immune response, antibody levels, T-cell immunity, recovered individuals, reinfection, immunity duration, SARS-CoV-2, adaptive immunity, long-term immunity, immune memory, neutralizing antibodies, cellular immunity, protective immunity, convalescent response COVID-19, immune response, antibody levels, T-cell mediated immunity, reinfection, recovered individuals, immunity duration, protective immunity, SARS-CoV-2, immune memory
50	what is known about an mRNA vaccine for the SARS-CoV-2 virus? mRNA vaccine, SARS-CoV-2, COVID-19, vaccine development, coronavirus, mRNA technology, immune response, vaccine efficacy, clinical trials, Pfizer-BioNTech, Moderna, spike protein, vaccination, safety, effectiveness mRNA vaccine, SARS-CoV-2, COVID-19 vaccine, coronavirus vaccine, vaccine mechanism, immunization, mRNA technology, spike protein, vaccine efficacy, Pfizer-BioNTech, Moderna, vaccine development, clinical trials, immune response, vaccine safety, vaccination mRNA vaccine, SARS-CoV-2, COVID-19, coronavirus, vaccine development, immunization, spike protein, vaccine efficacy, clinical trials, Pfizer-BioNTech, Moderna, mRNA technology, immune response, vaccine safety, messenger RNA, vaccine research mRNA vaccine, SARS-CoV-2, COVID-19, coronavirus, vaccine development, efficacy, immune response, clinical trials, Moderna, Pfizer-BioNTech, spike protein, vaccine technology, safety, side effects, RNA vaccines, vaccination, mechanism of action mRNA vaccine, SARS-CoV-2, COVID-19, coronavirus, vaccine efficacy, vaccine technology, clinical trials, immune response, Pfizer-BioNTech, Moderna, spike protein, vaccine development, safety data, vaccination, RNA vaccines
10	has social distancing had an impact on slowing the spread of COVID-19? social distancing, COVID-19, impact, transmission, spread, effectiveness, pandemic, public health, infection rate, mitigation strategies social distancing, COVID-19, impact, transmission, spread, effectiveness, pandemic, epidemiology, public health, infection control, disease mitigation, virus, coronavirus, intervention measures, case reduction social distancing, COVID-19, impact, transmission, virus spread, pandemic, infection rate, effectiveness, public health interventions, slowing spread, coronavirus, epidemiology, mitigation measures, disease control, outbreak social distancing, impact, COVID-19, spread, transmission, coronavirus, effectiveness, mitigation, pandemic, infection rates, disease control, public health measures, epidemiology social distancing, COVID-19, impact, slowing spread, coronavirus, transmission, effectiveness, pandemic measures, infection rate, public health, mitigation, disease control
11	what are the guidelines for triaging patients infected with coronavirus? coronavirus, triage guidelines, patient triage, COVID-19, infection control, clinical protocols, emergency response, healthcare guidelines, patient management, screening criteria, pandemic response, hospital triage, infectious disease, SARS-CoV-2, medical guidelines coronavirus, triage, patient guidelines, COVID-19, infection protocols, triaging criteria, patient management, emergency care, clinical guidelines, pandemic response, healthcare protocols, infectious disease, screening procedures, severity assessment coronavirus, COVID-19, triage guidelines, patient triage, infection control, healthcare protocols, clinical guidelines, emergency management, pandemic response, patient prioritization, hospital protocols, screening criteria, infectious disease, medical triage, outbreak management coronavirus, triage guidelines, patient management, COVID-19, infection control, triaging protocols, clinical guidelines, emergency triage, pandemic response, patient prioritization, healthcare protocols, respiratory infection triage, outbreak management, hospital triage, infectious disease coronavirus, triage, patient guidelines, COVID-19, infection control, triaging protocols, medical guidelines, patient prioritization, emergency response, healthcare procedures, outbreak management
12	what are best practices in hospitals and at home in maintaining quarantine? hospital quarantine best practices, home quarantine guidelines, infection control measures, isolation procedures, disease prevention hospitals, quarantine protocols, home isolation tips, healthcare facility quarantine, COVID-19 quarantine, safe quarantine practices, home care quarantine, public health recommendations, quarantine safety hospitals quarantine, best practices, hospitals, home, infection control, isolation, patient management, hygiene, disinfection, personal protective equipment, COVID-19, disease prevention, outbreak response, healthcare guidelines, home care, safety protocols, containment measures, public health hospital quarantine, home quarantine, quarantine best practices, infection control, isolation procedures, hospital infection prevention, home isolation, quarantine guidelines, disease containment, hygiene protocols, patient management, COVID-19 quarantine, public health quarantine, sanitation measures, PPE usage, contact tracing, room ventilation, disinfection practices hospital quarantine, home quarantine, best practices, quarantine guidelines, isolation procedures, infection control, disease prevention, hospital protocols, home isolation, public health measures, contamination prevention, patient care, disinfection routines, personal protective equipment, COVID-19 quarantine, hygiene practices, quarantine management, safety protocols quarantine, best practices, hospitals, home, infection control, isolation, hygiene, safety protocols, COVID-19, patient care, disinfection, protective equipment, social distancing, disease prevention, public health, quarantine guidelines, containment measures, cleaning routines, medical protocols, home care
13	what are the transmission routes of coronavirus? coronavirus, transmission routes, covid-19, spread, infection pathways, how coronavirus spreads, modes of transmission, respiratory droplets, airborne transmission, contact transmission, surface transmission, fomite transmission, person-to-person spread, virus transmission, infectious disease coronavirus, transmission routes, covid-19, spreading, infection, how spreads, SARS-CoV-2, airborne, droplets, contact, surfaces, human-to-human, respiratory, contagion, virus pathways coronavirus, transmission routes, COVID-19, spread, infection, modes, airborne, droplets, contact, surfaces, respiratory, person-to-person, fecal-oral, aerosol, virus spread coronavirus, transmission routes, COVID-19, spread, infection pathways, airborne, droplets, contact, surfaces, respiratory, person-to-person coronavirus, transmission routes, COVID-19, spread, infection, transmission methods, airborne, droplets, contact, surfaces, respiratory, person-to-person
14	what evidence is there related to COVID-19 super spreaders COVID-19, super spreaders, evidence, transmission, SARS-CoV-2, epidemiology, outbreak, cluster, infection rates, asymptomatic carriers, viral load, transmission dynamics, contact tracing, case studies, superspreading events COVID-19, super spreaders, evidence, transmission, viral load, epidemiology, case studies, outbreak investigation, cluster analysis, infection rate, asymptomatic carriers, contact tracing, spread dynamics, superspreading events, risk factors COVID-19, super spreaders, evidence, transmission, clusters, case studies, epidemiology, outbreak, viral load, contact tracing, asymptomatic carriers, infection rate, spread dynamics, superspreading events, pandemic, public health, risk factors COVID-19, super spreaders, transmission, evidence, outbreak, viral load, case studies, contact tracing, epidemiology, infection clusters, asymptomatic carriers, risk factors, superspreading events, SARS-CoV-2, pandemic spread COVID-19, super spreaders, superspreading events, transmission, evidence, outbreaks, viral load, epidemiology, case studies, cluster infections, spread patterns, asymptomatic carriers, public health, contact tracing
15	how long can the coronavirus live outside the body coronavirus, survival time, outside body, surface lifespan, virus viability, COVID-19, environmental stability, surface survival, duration, air, objects, transmission risk, infectious period coronavirus, survival time, outside body, surface lifespan, COVID-19, virus viability, environment, surface transmission, virus survival duration, how long, infectious period, air, surfaces, materials, persistence, contamination, exposure time, fomite transmission, SARS-CoV-2 coronavirus, virus survival, surface lifespan, outside body, COVID-19 duration, virus viability, environmental stability, infectious period, virus persistence, surface transmission coronavirus, virus survival, outside body, surface lifespan, COVID-19, surface viability, virus duration, environmental stability, surfaces, transmission, infectious period, viral persistence coronavirus, virus survival, outside body, surface lifespan, COVID-19, virus duration, environmental stability, surface transmission, how long, coronavirus lifespan, surfaces, virus outside body
16	how long does coronavirus remain stable  on surfaces? coronavirus, surface stability, virus lifespan, virus survival, surface contamination, COVID-19, surface duration, virus persistence, environmental stability, how long, remain stable, surfaces coronavirus, surface stability, virus survival, surface persistence, COVID-19, surface longevity, virus duration, surface contamination, virus lifespan, virus stability, how long, remain viable, surface transmission coronavirus, surface stability, virus lifespan, surface contamination, COVID-19, virus survival time, surface transmission, environmental stability, SARS-CoV-2, virus persistence coronavirus, surface stability, virus lifespan, surface contamination, COVID-19, virus survival time, surface persistence, viral stability, coronavirus surfaces, environmental stability, SARS-CoV-2 coronavirus, surface stability, virus lifespan, surface contamination, COVID-19, virus survival time, surface transmission, virus persistence, environmental stability, infectious period surfaces
17	are there any clinical trials available for the coronavirus clinical trials, coronavirus, COVID-19, available studies, research studies, SARS-CoV-2, clinical research, trial recruitment, ongoing trials, interventional studies, clinical trial registry clinical trials, coronavirus, COVID-19, SARS-CoV-2, ongoing studies, available trials, participation, recruitment, investigational treatments, research studies, enrolling patients, trial locations clinical trials, coronavirus, COVID-19, SARS-CoV-2, available studies, ongoing trials, recruitment, treatment trials, vaccine trials, interventional studies, clinical research, trial registry coronavirus, COVID-19, clinical trials, ongoing trials, available studies, research studies, human trials, SARS-CoV-2, recruiting, treatment trials, vaccine trials, intervention studies clinical trials, coronavirus, COVID-19, available studies, research, clinical research, SARS-CoV-2, participant recruitment, ongoing trials, trial availability
18	what are the best masks for preventing infection by Covid-19? best masks, Covid-19, infection prevention, face masks, protective masks, N95, KN95, surgical masks, mask effectiveness, coronavirus, virus protection, respirators, medical masks, mask comparison, mask recommendations best masks, Covid-19, prevention, infection, face masks, protective masks, N95, surgical masks, respirators, mask effectiveness, coronavirus, mask comparison, filtration efficiency best masks, Covid-19 prevention, infection protection, N95 masks, surgical masks, respirators, face masks, coronavirus, mask effectiveness, mask types, filtering masks best masks, Covid-19, infection prevention, protective masks, N95, surgical masks, face masks, respiratory protection, mask effectiveness, coronavirus, mask types, pandemic, virus transmission, PPE, health safety best masks, Covid-19, infection prevention, mask effectiveness, protective masks, N95, KN95, surgical masks, face masks, coronavirus, respiratory protection, filtration efficiency, virus transmission, mask types, pandemic
19	what type of hand sanitizer is needed to destroy Covid-19? hand sanitizer, Covid-19, coronavirus, effectiveness, destroy, disinfectant, alcohol-based, virus, recommended, type, kill, concentration, ethanol, isopropyl alcohol, CDC, WHO, guidelines hand sanitizer, Covid-19, destroy, effective, type, alcohol-based, concentration, virus, kill, recommended, CDC, WHO, percentage, disinfectant, coronavirus hand sanitizer, Covid-19, destroy, effective, type, alcohol-based, percentage, disinfectant, virus, antibacterial, efficacy, WHO recommendations, CDC guidelines, ethyl alcohol, isopropyl alcohol hand sanitizer, Covid-19, recommended, type, effective, destroy, coronavirus, alcohol-based, disinfectant, percentage, ethanol, isopropanol, virus, CDC, WHO, kill hand sanitizer, Covid-19, coronavirus, effective, type, alcohol-based, destroy, kill, recommended, concentration, ethanol, isopropyl alcohol, percentage, disinfectant, virus, efficacy
1	what is the origin of COVID-19 COVID-19, origin, coronavirus, SARS-CoV-2, source, outbreak, Wuhan, history, initial cases, zoonotic, animal to human, beginnings, pandemic, cause COVID-19, origin, coronavirus, SARS-CoV-2, virus source, outbreak, Wuhan, zoonotic, pandemic, initial cases, emergence, beginnings, virology, virus origins, COVID origin sources COVID-19, origin, SARS-CoV-2, coronavirus, source, outbreak, Wuhan, China, initial cases, zoonotic transmission, animal host, pandemic, emergence, history, beginnings COVID-19, origin, SARS-CoV-2, coronavirus, outbreak, source, transmission, Wuhan, China, initial cases, zoonotic, animal reservoir, history, pandemic, causes COVID-19, origin, source, coronavirus, emergence, Wuhan, China, virus origin, outbreak, initial cases, zoonotic, animal reservoir, transmission, start, history, beginning
2	how does the coronavirus respond to changes in the weather coronavirus, weather, COVID-19, climate, temperature, humidity, virus transmission, seasonal effects, SARS-CoV-2, environmental factors, pandemic, disease spread, viral response, epidemiology coronavirus, COVID-19, weather, climate, temperature, humidity, seasonal variation, virus transmission, environmental factors, virus survival, pandemic, respiratory viruses, infection rates, virus stability coronavirus, COVID-19, weather, temperature, humidity, seasonal variation, virus transmission, climate, SARS-CoV-2, environmental factors, virus survival, pandemic, meteorological impact coronavirus, COVID-19, virus, weather, climate, temperature, humidity, seasonal variation, transmission, environmental factors, virus survival, impact, SARS-CoV-2, spread, infection rate coronavirus, COVID-19, weather, climate, temperature, humidity, seasonal variation, virus transmission, environmental factors, virus survival, pandemic, infection rates, meteorological impact, SARS-CoV-2
3	will SARS-CoV2 infected people develop immunity? Is cross protection possible? SARS-CoV-2, immunity development, immune response, coronavirus, cross protection, reinfection, antibodies, T-cell response, protection duration, immune memory, cross-reactivity, COVID-19, natural immunity, adaptive immunity, variant immunity SARS-CoV-2, immunity, COVID-19, reinfection, immune response, antibody, cross protection, cross-reactivity, long-term immunity, T cells, coronavirus, immune memory, protection, infection, neutralizing antibodies SARS-CoV-2, COVID-19, immunity development, immune response, infection, cross-protection, cross-immunity, antibodies, reinfection, adaptive immunity, coronavirus, immune memory, protection, recovery, long-term immunity, T cells, B cells SARS-CoV-2, COVID-19, immunity, immune response, infection, cross protection, cross-immunity, reinfection, antibody response, T-cell response, immune memory, coronavirus, protective immunity, viral immunity, immune system SARS-CoV-2, immunity, infected individuals, immune response, cross protection, cross immunity, COVID-19, antibody development, reinfection, long-term immunity, coronavirus, T-cell response, immune memory, protection duration, variant immunity
4	what causes death from Covid-19? Covid-19, death causes, mortality, risk factors, complications, SARS-CoV-2, respiratory failure, comorbidities, cytokine storm, pneumonia, acute respiratory distress syndrome, organ failure, immune response, infection severity, underlying conditions Covid-19, causes, death, mortality, risk factors, complications, severe cases, respiratory failure, cytokine storm, pneumonia, comorbidities, organ failure, ARDS, infection, underlying conditions, virus, immune response Covid-19, death causes, mortality factors, SARS-CoV-2, complications, respiratory failure, comorbidities, cytokine storm, organ failure, risk factors, acute respiratory distress syndrome, pneumonia, pre-existing conditions, age, severe symptoms Covid-19, death causes, mortality, risk factors, complications, severe illness, respiratory failure, cytokine storm, comorbidities, organ failure, ARDS, pneumonia Covid-19, causes, death, fatality, mortality, risk factors, complications, respiratory failure, pneumonia, cytokine storm, organ failure, comorbidities, severe infection, underlying conditions, immune response, ARDS, coagulation, thrombosis
5	what drugs have been active against SARS-CoV or SARS-CoV-2 in animal studies? SARS-CoV, SARS-CoV-2, drugs, active, antiviral agents, animal studies, preclinical, efficacy, in vivo, mouse model, therapeutic, treatment, coronavirus, drug candidates, animal models, pharmacology, experimental therapy, MERS, COVID-19, remdesivir, monoclonal antibodies, favipiravir, hydroxychloroquine, lopinavir, ritonavir, interferon SARS-CoV, SARS-CoV-2, drugs, animal studies, antiviral agents, therapeutic efficacy, in vivo, preclinical studies, pharmacology, drug candidates, coronavirus, experimental models, treatment, repurposed drugs, efficacy, antivirals, animal models SARS-CoV, SARS-CoV-2, animal studies, antiviral drugs, efficacy, preclinical, therapeutic agents, coronavirus, in vivo, animal models, drug candidates, experimental treatment, pharmacology, COVID-19, MERS-CoV, inhibition, viral replication, animal testing SARS-CoV, SARS-CoV-2, antiviral drugs, animal studies, preclinical, therapeutic agents, in vivo, coronavirus, efficacy, pharmacology, drug candidates, experimental treatments, animal models, COVID-19, MERS-CoV, broad-spectrum antivirals SARS-CoV, SARS-CoV-2, drugs, antiviral, animal studies, efficacy, preclinical, in vivo, therapeutic agents, coronavirus, treatment, experimental, pharmacology, drug candidates, animal models, efficacy studies, therapeutic efficacy, intervention, preclinical research, viral inhibition
6	what types of rapid testing for Covid-19 have been developed? Covid-19, rapid testing, diagnostic methods, antigen test, PCR test, molecular test, point-of-care test, lateral flow assay, saliva test, home test kits, RT-PCR, nucleic acid amplification, detection methods, coronavirus testing, diagnostic tools rapid testing, Covid-19, types, developed, antigen tests, PCR tests, molecular tests, point-of-care, diagnostic tests, home testing, lateral flow, RT-PCR, NAAT, saliva tests, swab tests rapid testing, Covid-19, types, developed, antigen test, PCR test, molecular test, antibody test, diagnostic methods, coronavirus, SARS-CoV-2, detection, point-of-care, lateral flow test, nucleic acid amplification test, NAAT, home test kits Covid-19, rapid testing, test types, diagnostic methods, antigen tests, PCR tests, molecular tests, lateral flow assays, point-of-care tests, rapid diagnostic tests, saliva tests, home tests, swab tests, detection methods, COVID testing technology rapid Covid-19 testing, Covid-19 test types, Covid-19 detection methods, antigen test, PCR test, molecular test, lateral flow test, point-of-care Covid test, Covid-19 diagnostics, Covid-19 rapid assay, antibody test, Covid-19 screening methods
7	are there serological tests that detect antibodies to coronavirus? serological tests, antibody detection, coronavirus, COVID-19, SARS-CoV-2, antibody test, serology, diagnostic tests, immune response, seroprevalence, blood test, IgG, IgM, ELISA, rapid test serological tests, antibody detection, coronavirus, COVID-19, SARS-CoV-2 antibodies, serology, immune response, diagnostic tests, antibody test, coronavirus infection, serological assays, IgG, IgM, seroprevalence serological tests, antibody detection, coronavirus, COVID-19, SARS-CoV-2, antibody tests, serology, immune response, diagnostic tests, antibody assays serological tests, antibody detection, coronavirus, COVID-19, SARS-CoV-2, serology, immune response, diagnostic tests, antibody assay, immunoassay, virus antibodies serological tests, antibody detection, coronavirus, COVID-19, SARS-CoV-2, serology, immune response, antibody test, diagnostic tests, virus antibodies
8	how has lack of testing availability led to underreporting of true incidence of Covid-19? Covid-19, testing availability, underreporting, true incidence, case detection, testing capacity, diagnosis rates, test shortage, case numbers, pandemic, surveillance, infection rates, data accuracy, public health, asymptomatic cases covid-19, testing availability, underreporting, incidence, case detection, test access, surveillance, unreported cases, public health, diagnostic shortages, pandemic, data accuracy, misreporting, infection rates, covid incidence, test shortages testing availability, Covid-19, underreporting, true incidence, test access, case detection, surveillance, pandemic, diagnostic capacity, reported cases, public health, reporting bias, test shortages, infection rates, testing limitations Covid-19, underreporting, incidence, lack of testing, testing availability, surveillance, case detection, true prevalence, diagnostic capacity, testing shortages, data accuracy, unreported cases, public health, asymptomatic cases, epidemiology Covid-19, underreporting, testing availability, true incidence, case detection, testing scarcity, surveillance, case reporting, data accuracy, pandemic, test access, infection rate, diagnostic limitations, case numbers, public health
9	how has COVID-19 affected Canada COVID-19, Canada, impact, effects, pandemic, coronavirus, economic impact, health impact, social impact, government response, statistics, cases, vaccines, lockdown, unemployment, public health, policy, recovery, mental health, restrictions, healthcare system COVID-19, Canada, impact, effects, pandemic, coronavirus, economy, health, society, government response, statistics, cases, fatalities, public health, restrictions, recovery, unemployment, mental health, vaccine, lockdown COVID-19, impact, Canada, effects, pandemic, economic effects, healthcare, social impact, public health, Canadian response, unemployment, government measures, vaccination, lockdown, mental health, travel restrictions, infection rates COVID-19, pandemic, impact, Canada, effects, coronavirus, public health, economy, social, cases, response, government measures, healthcare, unemployment, restrictions, vaccination, travel, mental health, statistics, recovery COVID-19, Canada, impact, effects, pandemic, coronavirus, public health, economy, social changes, unemployment, healthcare, government response, vaccination, mental health, travel restrictions, lockdown, cases, mortality, recovery, policies
20	are patients taking Angiotensin-converting enzyme inhibitors (ACE) at increased risk for COVID-19? ACE inhibitors, COVID-19 risk, angiotensin-converting enzyme inhibitors, patient risk, COVID-19 susceptibility, ACE inhibitors and coronavirus, ACEi, SARS-CoV-2, hypertension medication, COVID-19 outcomes, ACE inhibitor safety, cardiovascular disease, COVID-19 comorbidity, ACE inhibitor therapy, infection risk ACE inhibitors, angiotensin-converting enzyme inhibitors, COVID-19 risk, SARS-CoV-2, ACE inhibitors COVID-19, antihypertensive drugs, patient risk factors, coronavirus, medication outcomes, COVID-19 susceptibility, comorbidities, hypertension, RAAS inhibitors, ACEIs, drug safety, infection risk, observational studies, clinical outcomes, disease severity, COVID-19 complications ACE inhibitors, COVID-19 risk, angiotensin-converting enzyme, patient risk, ACEI, susceptibility, coronavirus, comorbidity, antihypertensive drugs, COVID-19 outcomes, medication risk, SARS-CoV-2, hypertension, ACE medication, COVID-19 susceptibility ACE inhibitors, Angiotensin-converting enzyme inhibitors, COVID-19, SARS-CoV-2, risk factors, patients, susceptibility, infection risk, hypertension, comorbidities, medication, cardiovascular disease, outcomes, ACEI, coronavirus, clinical studies, safety, pandemic, drug interactions, prognosis ACE inhibitors, angiotensin-converting enzyme inhibitors, COVID-19 risk, COVID-19 susceptibility, ACE inhibitors and COVID-19, patient risk factors, coronavirus, antihypertensive medication, SARS-CoV-2, hypertension, comorbidities, ACE inhibitors safety, cardiovascular disease, COVID-19 outcomes, medication risk
21	what are the mortality rates overall and in specific populations mortality rates, overall mortality, population-specific mortality, demographic mortality, age-specific mortality, ethnicity mortality rates, gender mortality rates, regional mortality rates, mortality statistics, population groups, health disparities, mortality data, cause-specific mortality mortality rates, overall mortality, population-specific mortality, demographic mortality, mortality statistics, mortality by population, age-specific mortality, gender mortality rates, regional mortality rates, ethnic mortality rates, mortality data, mortality trends, cause-specific mortality mortality rates, overall mortality, population-specific mortality, demographic mortality, mortality statistics, age-specific mortality, gender mortality rates, ethnic mortality rates, mortality by population, mortality data, mortality differences, mortality comparison, mortality trends, subgroup mortality mortality rates, overall mortality, population-specific mortality, demographic mortality, subgroup mortality rates, mortality statistics, death rates, age-specific mortality, gender mortality, ethnic mortality, mortality by region, population mortality data, mortality trends mortality rates, overall mortality, population-specific mortality, demographic mortality, mortality statistics, age-specific mortality, gender-specific mortality, ethnicity mortality, risk factors, mortality trends, population mortality rates, cause-specific mortality
22	are cardiac complications likely in patients with COVID-19? COVID-19, cardiac complications, heart issues, cardiovascular risk, SARS-CoV-2, myocarditis, arrhythmia, acute coronary syndrome, COVID-19 patients, heart failure, cardiac injury, COVID-associated cardiomyopathy, prognosis, comorbidities, clinical outcomes cardiac complications, COVID-19, cardiovascular risk, heart disease, coronavirus, myocardial injury, cardiac involvement, COVID-19 patients, cardiac risk factors, SARS-CoV-2, heart complications, acute cardiac events, COVID-19 outcomes, comorbidities, myocarditis cardiac complications, COVID-19, heart issues, cardiovascular risk, COVID-19 patients, myocarditis, arrhythmia, cardiac injury, SARS-CoV-2, heart failure, cardiac outcomes, risk factors, COVID-19 severity, co-morbidities, prognosis cardiac complications, COVID-19, likelihood, cardiovascular risk, SARS-CoV-2, heart involvement, myocarditis, arrhythmia, COVID-19 patients, cardiac injury, COVID-19 outcomes, comorbidities, prognosis, cardiovascular complications cardiac complications, COVID-19, cardiovascular risk, heart problems, SARS-CoV-2, cardiac injury, myocarditis, COVID-19 patients, cardiovascular disease, COVID-19 complications, heart failure, arrhythmia, myocardial infarction, cardiac events, COVID-19 outcomes
23	what kinds of complications related to COVID-19 are associated with hypertension? COVID-19, complications, hypertension, high blood pressure, cardiovascular, risk factors, comorbidities, severe outcomes, mortality, respiratory complications, organ damage, hospitalization COVID-19, complications, hypertension, high blood pressure, cardiovascular disease, comorbidities, risk factors, severity, mortality, outcomes, respiratory complications, kidney damage, inflammation, thromboembolism, ICU admission, organ failure COVID-19, complications, hypertension, cardiovascular, comorbidities, risk factors, severe outcomes, blood pressure, mortality, hospitalization, infection, respiratory complications, acute complications, chronic complications, inflammation, organ damage, pre-existing conditions, disease severity, prognosis COVID-19, complications, hypertension, comorbidities, cardiovascular risk, COVID-19 outcomes, high blood pressure, COVID-19 severity, COVID-19 mortality, COVID-19 patients, long-term effects, predisposition, vascular complications, respiratory complications, COVID-19 clinical features COVID-19, complications, hypertension, comorbidities, cardiovascular, high blood pressure, risk factors, severe outcomes, mortality, acute respiratory distress, organ damage, thromboembolism, renal impairment
24	what kinds of complications related to COVID-19 are associated with diabetes COVID-19, diabetes, complications, risk factors, comorbidity, severe outcomes, hyperglycemia, mortality, hospitalization, infection, inflammation, immune response, respiratory complications, cardiovascular complications, kidney complications, prognosis, management COVID-19, complications, diabetes, comorbidities, risk factors, severity, outcomes, infection, hyperglycemia, mortality, hospitalization, respiratory complications, cardiovascular complications, immune response, diabetic patients, prognosis COVID-19, complications, diabetes, COVID-19 complications, diabetes comorbidities, infection risk, hyperglycemia, pneumonia, acute respiratory distress syndrome, ARDS, cardiovascular complications, kidney injury, cytokine storm, immune response, severe outcomes, hospitalization, mortality, diabetic patients, comorbidity, inflammation, COVID-19 severity COVID-19, complications, diabetes, association, risks, comorbidities, severe outcomes, hyperglycemia, infection, morbidity, mortality, inflammation, diabetic patients, viral infection, immune response, respiratory complications, cardiovascular complications, hospitalization, prognosis, blood glucose COVID-19, complications, diabetes, comorbidities, risks, outcomes, infection, severity, hyperglycemia, respiratory distress, inflammation, cytokine storm, mortality, hospitalization, long-term effects, immunosuppression, organ damage, blood glucose, diabetic ketoacidosis, secondary infections
25	which biomarkers predict the severe clinical course of 2019-nCOV infection? biomarkers, severe, clinical course, 2019-nCOV, COVID-19, SARS-CoV-2, prediction, prognosis, risk factors, disease severity, inflammatory markers, cytokines, CRP, D-dimer, lymphopenia, IL-6, ferritin, lactate dehydrogenase, procalcitonin, neutrophil-to-lymphocyte ratio biomarkers, severe, clinical course, 2019-nCOV, COVID-19, predictors, prognosis, severity, laboratory markers, risk factors, inflammatory markers, cytokines, mortality, disease progression, acute respiratory distress, lymphopenia, C-reactive protein, D-dimer, ferritin, lactate dehydrogenase, interleukin-6 biomarkers, severity, predictors, clinical course, 2019-nCOV, COVID-19, SARS-CoV-2, infection, prognosis, risk factors, inflammatory markers, cytokines, C-reactive protein, D-dimer, lymphopenia, ferritin, interleukin-6, troponin, lactate dehydrogenase, acute phase reactants biomarkers, severe, clinical course, 2019-nCOV, COVID-19, predictors, severity, prognosis, infection, laboratory markers, cytokines, inflammation, risk factors, mortality, progression biomarkers, severe, clinical course, prediction, 2019-nCoV, COVID-19, SARS-CoV-2, severity, prognostic indicators, risk factors, laboratory markers, cytokines, inflammation, immune response, mortality, disease progression
26	what are the initial symptoms of Covid-19? Covid-19, initial symptoms, early signs, coronavirus, first symptoms, infection symptoms, onset Covid-19, early Covid signs, Covid warning signs initial symptoms, Covid-19, early signs, coronavirus, first symptoms, Covid infection, common symptoms, early Covid, covid indicators, onset Covid-19 initial symptoms, Covid-19, early signs, coronavirus, first symptoms, Covid onset, Covid infection, mild symptoms, clinical presentation, Covid-19 indicators, early Covid, coronavirus symptoms initial symptoms, Covid-19, early signs, coronavirus, first symptoms, Covid, clinical presentation, onset symptoms, Covid symptoms, early indicators, SARS-CoV-2, infection signs, Covid-19 diagnosis, acute symptoms initial symptoms, Covid-19, early signs, coronavirus, first symptoms, Covid onset, Covid indicators, infection signs, early Covid symptoms, coronavirus symptoms
27	what is known about those infected with Covid-19 but are asymptomatic? Covid-19, asymptomatic, infection, asymptomatic carriers, Covid transmission, silent spreaders, viral load, symptomless, epidemiology, public health, disease spread, infectiousness, asymptomatic rate, risk factors, immunity Covid-19, asymptomatic, infected, clinical characteristics, transmission, viral load, epidemiology, symptomless, carriers, SARS-CoV-2, immune response, public health, spread, infection rate, risk factors Covid-19, asymptomatic, infection, asymptomatic carriers, disease transmission, viral load, symptomless, epidemiology, silent spreaders, immune response, contagiousness, prevalence, risk factors, clinical characteristics, viral shedding Covid-19, asymptomatic, infection, characteristics, transmission, epidemiology, prevalence, viral load, immune response, disease progression, contagiousness, silent carriers, risk factors, outcomes, symptomless, detection, testing, public health, spread, research, studies Covid-19, asymptomatic, infected, transmission, viral load, epidemiology, disease spread, symptomless, carriers, infection rate, testing, immune response, public health, contagiousness, silent spreaders
28	what evidence is there for the value of hydroxychloroquine in treating Covid-19? hydroxychloroquine, Covid-19, coronavirus, treatment, efficacy, clinical trials, evidence, therapeutic value, research studies, outcomes, antiviral, effectiveness, SARS-CoV-2, medical evidence, study results, patient recovery, randomized controlled trials, meta-analysis, systematic review, drug therapy, controversy, public health, safety hydroxychloroquine, Covid-19, evidence, treatment, clinical trials, efficacy, outcomes, antiviral, studies, research, benefit, coronavirus, SARS-CoV-2, results, effectiveness, review, meta-analysis, safety, findings, data hydroxychloroquine, Covid-19, evidence, clinical trials, treatment efficacy, SARS-CoV-2, antiviral, randomized controlled trials, outcomes, meta-analysis, systematic review, safety, effectiveness, recovery rate, hospitalization, mortality, peer-reviewed studies hydroxychloroquine, Covid-19, treatment, efficacy, clinical trials, evidence, effectiveness, outcomes, studies, antiviral, research, systematic review, meta-analysis, SARS-CoV-2, therapeutic value hydroxychloroquine, Covid-19, treatment, clinical trials, evidence, efficacy, studies, results, therapeutic value, antiviral, outcomes, controlled trials, meta-analysis, systematic review, SARS-CoV-2
29	which SARS-CoV-2 proteins-human proteins interactions indicate potential for drug targets. Are there approved drugs that can be repurposed based on this information? SARS-CoV-2, human protein interactions, drug targets, protein-protein interaction, approved drugs, drug repurposing, antiviral therapy, COVID-19, host-pathogen interaction, therapeutic targets, interactome, inhibitor, pharmacology, viral-host interaction, cheminformatics, drug discovery, molecular docking, mechanism of action, protein binding, immunomodulators, FDA approved drugs, computational screening, clinical trials SARS-CoV-2, human protein interactions, virus-host interactome, drug targets, protein-protein interactions, approved drugs, drug repurposing, therapeutic targets, antiviral agents, host factors, COVID-19, pharmacological intervention, viral entry, clinical drugs, molecular docking, druggable proteins, interaction network, virus replication, FDA-approved drugs, host-pathogen interaction SARS-CoV-2, human protein interactions, protein-protein interactions, drug targets, approved drugs, drug repurposing, antiviral, therapeutic targets, host-pathogen interactions, viral proteins, human host proteins, COVID-19, interactome, small molecule inhibitors, existing drugs, drug discovery, mechanism of action, pharmacology, protein binding, clinical trials, drug repositioning SARS-CoV-2, viral-host protein interactions, human proteins, drug targets, protein-protein interactions, approved drugs, drug repurposing, therapeutic targets, host-pathogen interactions, antiviral drugs, interactome, COVID-19, pharmacological intervention, candidate drugs, molecular docking, clinical drugs, network analysis, druggable proteins SARS-CoV-2, protein-protein interactions, human proteins, drug targets, therapeutic targets, host-pathogen interaction, approved drugs, drug repurposing, interactome, antiviral agents, COVID-19, candidate drugs, molecular docking, inhibition, pharmacology, viral proteins, host factors, clinical trials, drug databases, DrugBank, protein interaction map, therapeutic intervention, compound screening
30	is remdesivir an effective treatment for COVID-19 remdesivir, COVID-19, effectiveness, treatment, antiviral, clinical trials, efficacy, coronavirus, therapeutic, outcomes remdesivir, COVID-19, effectiveness, antiviral treatment, clinical trials, SARS-CoV-2, efficacy, therapy, outcomes, research studies remdesivir, COVID-19, treatment efficacy, antiviral therapy, clinical trials, effectiveness, SARS-CoV-2, therapeutic outcomes, patient recovery, evidence-based, randomized controlled trial, pharmacology, mortality rate, viral load, FDA approval remdesivir, COVID-19, effectiveness, treatment, antiviral, clinical trials, efficacy, therapy, SARS-CoV-2, patient outcomes, drug therapy, coronavirus, hospitalization, recovery rate, research studies remdesivir, effectiveness, treatment, COVID-19, antiviral, clinical trials, efficacy, coronavirus, SARS-CoV-2, therapy, outcomes, studies, FDA approval, hospital, mortality, recovery, safety
31	How does the coronavirus differ from seasonal flu? coronavirus, COVID-19, seasonal flu, influenza, differences, symptoms, transmission, severity, mortality rate, incubation period, virus structure, contagiousness, prevention, treatment coronavirus, COVID-19, seasonal flu, influenza, differences, symptoms, transmission, mortality rate, incubation period, vaccine, treatment, virus structure, contagiousness, prevention, recovery time coronavirus, COVID-19, seasonal flu, influenza, differences, symptoms, transmission, severity, mortality rate, incubation period, treatment, prevention coronavirus, COVID-19, seasonal flu, influenza, differences, symptoms, transmission, mortality rate, incubation period, contagiousness, prevention, treatment, virus structure, immune response, vaccine, diagnosis coronavirus, COVID-19, seasonal flu, influenza, differences, symptoms, transmission, incubation period, severity, mortality rate, prevention, vaccines, treatment, contagiousness, virus structure
32	Does SARS-CoV-2 have any subtypes, and if so what are they? SARS-CoV-2, variants, subtypes, lineages, classification, mutant strains, virus taxonomy, COVID-19 variants, genetic diversity, clades, WHO variant names, PANGO lineages, Alpha variant, Delta variant, Omicron variant SARS-CoV-2, subtypes, variants, lineages, COVID-19, strains, classification, genomics, mutation, clades, virus types, nomenclature, phylogeny, Alpha, Beta, Delta, Omicron SARS-CoV-2, subtypes, variants, lineages, COVID-19, virus classification, strain, genetic diversity, mutation, clades, VOC, VOI, viral evolution SARS-CoV-2, subtypes, variants, lineages, strains, classification, genetic diversity, mutation, COVID-19, nomenclature, Delta variant, Omicron variant, Alpha variant, Beta variant, Gamma variant, variant names, WHO classification, PANGO lineage, virus evolution SARS-CoV-2, subtypes, variants, lineages, virus classification, COVID-19, genomic diversity, strain differences, mutation types, variant names, Alpha, Beta, Delta, Omicron, viral evolution, phylogenetics
33	What vaccine candidates are being tested for Covid-19? Covid-19, vaccine candidates, clinical trials, SARS-CoV-2, vaccine development, mRNA vaccines, adenovirus vaccines, protein subunit vaccines, inactivated vaccines, vaccine trials, pharmaceutical companies, vaccine platforms, experimental vaccines, vaccine pipeline, WHO vaccine tracker, immunization, vaccine efficacy Covid-19, vaccine candidates, clinical trials, SARS-CoV-2, vaccine development, mRNA vaccines, adenovirus vaccines, inactivated vaccines, protein subunit vaccines, vaccine pipeline, ongoing trials, COVID vaccines, vaccine research, phase 1 trials, phase 2 trials, phase 3 trials, novel coronavirus, immunization, vaccine efficacy, vaccine safety Covid-19, vaccine candidates, clinical trials, SARS-CoV-2, vaccine development, testing, experimental vaccines, coronavirus vaccines, mRNA vaccines, protein subunit vaccines, viral vector vaccines Covid-19, vaccine candidates, clinical trials, SARS-CoV-2, Covid-19 vaccines, vaccine development, experimental vaccines, vaccine pipeline, investigational vaccines, vaccine research, candidate vaccines, Covid-19 immunization, vaccine efficacy, vaccine testing, vaccine studies Covid-19, vaccine candidates, clinical trials, SARS-CoV-2, vaccine development, experimental vaccines, vaccine efficacy, vaccine safety, phase 1 trials, phase 2 trials, phase 3 trials, RNA vaccines, mRNA vaccines, viral vector vaccines, protein subunit vaccines, inactivated vaccines, vaccine testing, coronavirus vaccines
34	What are the longer-term complications of those who recover from COVID-19? long-term complications, COVID-19 recovery, post-acute sequelae, long COVID, persistent symptoms, post-COVID syndrome, COVID-19 aftereffects, chronic effects, COVID-19 survivors, ongoing symptoms, COVID-19 complications, lasting effects, health outcomes, COVID-19 morbidity COVID-19, long-term complications, post-COVID syndrome, long COVID, sequelae, recovered patients, persistent symptoms, health outcomes, chronic effects, COVID-19 survivors, aftereffects, recovery, long-term effects, medical complications, COVID-19 aftermath long-term complications, post-acute COVID-19, COVID-19 sequelae, COVID-19 recovery effects, long COVID, post-COVID syndrome, chronic COVID symptoms, persistent COVID effects, COVID-19 survivors, lasting health effects, COVID-19 complications long-term complications, post-COVID-19, COVID-19 sequelae, COVID-19 recovery, persistent symptoms, long COVID, chronic effects, post-acute COVID-19, lingering symptoms, COVID-19 aftermath, after effects, COVID-19 survivors, health outcomes, post-COVID syndrome, COVID-19 complications long-term complications, post-COVID-19, COVID-19 sequelae, COVID-19 recovery, persistent symptoms, long COVID, aftereffects, post-acute COVID, lingering symptoms, COVID-19 survivors, chronic effects, lasting impact, health outcomes, COVID-19 complications, post-viral syndrome
35	What new public datasets are available related to COVID-19? new, public datasets, COVID-19, coronavirus, data release, latest, available, open data, pandemic, health data, medical, epidemiology, research, 2024, government, academic, global, updates new, public datasets, COVID-19, coronavirus, recent, released, available, data sources, pandemic, open data, 2024, health data, research, epidemiology, case numbers, vaccination data, variant data, genomic data, surveillance, global, statistics new public datasets, COVID-19, coronavirus, open data, released datasets, pandemic, recent datasets, health data, epidemiology, data repositories, COVID research, healthcare datasets, 2023 datasets, global datasets, outbreak data new, public datasets, COVID-19, coronavirus, open data, recent, released, updated, epidemiology, health data, pandemic, available, public health, 2024, data repository, virus, data portal, disease surveillance, medical data, global datasets new, public datasets, COVID-19, coronavirus, pandemic, open data, 2024, recent releases, health data, epidemiology, case counts, vaccination data, genomic data, mobility data, public health, infection rates, hospitalizations, open access, government datasets, research data
36	What is the protein structure of the SARS-CoV-2 spike? SARS-CoV-2, spike protein, protein structure, coronavirus, 3D structure, Cryo-EM, molecular structure, S protein, COVID-19, structural biology, envelope glycoprotein, protein folding, trimeric structure, receptor-binding domain, RBD, prefusion conformation SARS-CoV-2, spike protein, protein structure, coronavirus, 3D structure, cryo-EM, X-ray crystallography, amino acid sequence, protein folding, S protein, molecular structure, receptor binding domain, RBD, trimeric spike, viral entry, COVID-19 SARS-CoV-2, spike protein, protein structure, 3D structure, cryo-EM, coronavirus, S protein, viral entry, structural biology, receptor binding domain, trimeric structure, amino acid sequence, molecular structure SARS-CoV-2, spike protein, protein structure, coronavirus, 3D structure, molecular structure, spike glycoprotein, COVID-19, Cryo-EM, X-ray crystallography, PDB, receptor binding domain, S protein, structural biology SARS-CoV-2, spike protein, protein structure, coronavirus, Cryo-EM, X-ray crystallography, molecular structure, COVID-19, trimeric spike, receptor binding domain, S protein, protein folding, viral entry, structure determination, spike glycoprotein
37	What is the result of phylogenetic analysis of SARS-CoV-2 genome sequence? phylogenetic analysis, SARS-CoV-2, genome sequence, evolutionary relationship, COVID-19, viral lineage, genetic diversity, mutation, phylogeny, clade, sequence comparison, molecular epidemiology, virus origin, genome sequencing, strain classification phylogenetic analysis, SARS-CoV-2, genome sequence, evolutionary relationships, viral lineage, COVID-19, genetic variation, sequence comparison, phylogeny, mutation analysis, clade classification, genomic epidemiology, coronavirus, virus evolution, molecular epidemiology phylogenetic analysis, SARS-CoV-2, genome sequence, evolutionary relationship, viral lineage, genetic diversity, COVID-19, sequence variation, phylogeny, mutation analysis, strain classification, genomic epidemiology, SARS-CoV-2 evolution, sequence comparison, viral clades phylogenetic analysis, SARS-CoV-2, genome sequence, evolutionary relationship, viral lineage, genetic variation, phylogeny, COVID-19, sequence comparison, viral evolution, clade, mutation, genomic epidemiology phylogenetic analysis, SARS-CoV-2, genome sequence, evolutionary relationships, genetic diversity, lineage, variants, molecular epidemiology, COVID-19, virus classification, sequence comparison, phylogeny, clade, mutation analysis, viral evolution
38	What is the mechanism of inflammatory response and pathogenesis of COVID-19 cases? COVID-19, mechanism, inflammatory response, pathogenesis, immune response, cytokine storm, SARS-CoV-2, virus-host interaction, inflammation, immune dysregulation, pathophysiology, molecular mechanisms, lung injury, cytokines, chemokines, ACE2 receptor, viral replication, host response, immunopathology, disease progression COVID-19, inflammatory response, mechanism, pathogenesis, immune response, SARS-CoV-2, cytokine storm, infection, inflammation, disease progression, immune system, viral pathogenesis, interleukins, macrophages, T cells, lung inflammation, acute respiratory distress syndrome, ARDS, pro-inflammatory cytokines, innate immunity inflammatory response, pathogenesis, COVID-19, SARS-CoV-2, immune response, cytokine storm, innate immunity, adaptive immunity, viral pathogenesis, immunopathology, inflammation, host response, disease mechanism, coronavirus, lung inflammation, pro-inflammatory cytokines inflammatory response, COVID-19, mechanism, pathogenesis, immune response, cytokine storm, SARS-CoV-2, viral pathogenesis, lung inflammation, immune dysregulation, innate immunity, adaptive immunity, pro-inflammatory cytokines, ACE2 receptor, viral entry, immune cells, disease progression, COVID-19 pathology mechanism, inflammatory response, pathogenesis, COVID-19, SARS-CoV-2, immune response, cytokine storm, pathophysiology, infection, inflammation, viral replication, host immunity, lung injury, ACE2 receptor, immune dysregulation, pro-inflammatory cytokines, acute respiratory distress syndrome, disease progression, immunopathology
39	What is the mechanism of cytokine storm syndrome on the COVID-19? cytokine storm, mechanism, COVID-19, pathophysiology, immune response, inflammatory cascade, SARS-CoV-2, cytokine release syndrome, hyperinflammation, interleukins, immune dysregulation, pro-inflammatory cytokines, viral infection, immune system, severe COVID-19 cytokine storm, mechanism, COVID-19, pathophysiology, immune response, hyperinflammation, SARS-CoV-2, cytokine release, inflammation, immune dysregulation cytokine storm, cytokine storm syndrome, mechanism, COVID-19, SARS-CoV-2, immune response, pathogenesis, hyperinflammation, pro-inflammatory cytokines, IL-6, TNF-alpha, clinical features, molecular pathways, antiviral response, immune dysregulation cytokine storm, COVID-19, mechanism, pathophysiology, immune response, hyperinflammation, SARS-CoV-2, inflammatory cytokines, immune dysregulation, cytokine release syndrome, IL-6, TNF-alpha, interferons, disease progression, lung injury, severe COVID-19, immune system, molecular mechanisms cytokine storm, mechanism, COVID-19, pathogenesis, immune response, hyperinflammation, SARS-CoV-2, cytokines, inflammatory pathways, immune dysregulation, interleukins, TNF-alpha, IL-6, clinical features, severe COVID-19
40	What are the observed mutations in the SARS-CoV-2 genome and how often do the mutations occur? SARS-CoV-2, genome, observed mutations, mutation frequency, mutation rate, variants, genetic variation, spike protein mutations, nucleotide changes, viral evolution, mutation patterns, COVID-19, genomic sequencing, epidemiology, viral mutations SARS-CoV-2, genome, mutations, observed mutations, mutation frequency, genetic variation, viral evolution, mutation rate, variant emergence, genomic surveillance, spike protein mutations, nucleotide changes, mutation hotspots, sequencing data, COVID-19, SARS-CoV-2 variants SARS-CoV-2, genome, mutations, observed mutations, mutation frequency, mutation rate, coronavirus, genetic variation, viral genome, sequence analysis, variant, spike protein mutations, genomic surveillance, COVID-19, nucleotide changes, amino acid substitution SARS-CoV-2, genome, mutations, observed mutations, mutation frequency, mutation rate, genetic variation, genomic analysis, COVID-19, sequence data, viral evolution, single nucleotide polymorphisms, spike protein mutations, variant tracking, mutation patterns, pandemic, viral genome surveillance SARS-CoV-2, genome, mutations, observed mutations, mutation frequency, mutation rate, variant, viral genome, genetic variation, sequence analysis, coronavirus, viral evolution, spike protein mutations, genomic changes, mutation prevalence
41	What are the impacts of COVID-19 among African-Americans that differ from the rest of the U.S. population? COVID-19, African-Americans, racial disparities, health impacts, United States, COVID outcomes, minority health, infection rates, mortality rates, healthcare access, comorbidities, socioeconomic factors, health equity, pandemic effects, racial differences COVID-19, African-Americans, health disparities, racial differences, United States, pandemic impact, mortality rates, infection rates, comorbidities, socioeconomic factors, healthcare access, minority health, COVID outcomes, public health, systemic inequality COVID-19, African-Americans, racial disparities, health impacts, U.S. population, COVID-19 outcomes, minority health, infection rates, mortality rates, healthcare access, socioeconomic factors, comorbidities, public health, pandemic, social determinants of health COVID-19, African-Americans, health disparities, racial differences, United States, pandemic impact, minority health, morbidity, mortality rates, socioeconomic factors, healthcare access, comorbidities, vaccine uptake, infection rates, systemic racism, public health, disease burden, social determinants, racial inequality, ethnic disparities COVID-19, African-Americans, racial disparities, health outcomes, U.S. population, infection rates, mortality rates, comorbidities, socioeconomic factors, healthcare access, systemic racism, public health, minority health, disparities in care, pandemic impact
42	Does Vitamin D impact COVID-19 prevention and treatment? Vitamin D, COVID-19, prevention, treatment, immune response, supplementation, infection risk, disease severity, coronavirus, immunity, clinical trials, outcomes, deficiency, respiratory infections, antiviral, public health Vitamin D, COVID-19, prevention, treatment, supplementation, immunity, SARS-CoV-2, infection risk, immune response, clinical trials, deficiency, respiratory infections, outcomes, therapy, coronavirus Vitamin D, COVID-19, prevention, treatment, immune response, coronavirus, supplementation, infection risk, clinical trials, deficiency, outcomes, respiratory infections, immune system, protection, severity, epidemiology, therapy, supplementation effects Vitamin D, COVID-19, coronavirus, prevention, treatment, immunity, immune response, supplementation, clinical trials, infection risk, disease severity, respiratory infections, vitamin deficiency, outcomes, SARS-CoV-2, inflammation Vitamin D, COVID-19, coronavirus, prevention, treatment, immune response, supplementation, SARS-CoV-2, infection risk, clinical trials, deficiency, outcomes, therapy, respiratory infections, immunity, vitamin D levels
43	How has the COVID-19 pandemic impacted violence in society, including violent crimes? COVID-19, pandemic, impact, violence, society, violent crimes, crime rates, social disruption, public health, crime trends, lockdown, domestic violence, community safety, criminal justice, social unrest COVID-19 pandemic, violence, violent crime, societal impact, crime rates, social unrest, domestic violence, pandemic effects, public safety, crime trends, mental health, lockdown, economic stress, community violence, criminal behavior COVID-19, pandemic, violence, violent crime, societal impact, crime rates, social unrest, domestic violence, public safety, crime trends, lockdown effects, pandemic-related crime, community violence, mental health, public health crisis, law enforcement, social isolation, economic impact, crime statistics, emergency response COVID-19 pandemic, violence, societal impact, violent crime, crime rates, pandemic effects, domestic violence, community safety, social unrest, crime trends, public health, lockdown, law enforcement, crime statistics, pandemic-related violence COVID-19, pandemic, impact, violence, society, violent crimes, crime rates, social effects, public safety, domestic violence, community violence, crime trends, coronavirus, lockdown, mental health, economic stress, unemployment, law enforcement, crime statistics, social unrest